About
Sir Menelas (Mene) Pangalos, Ph.D. joined our Board of Directors in January 2025 and is a member of our Compensation and Management Development Committee. Prof Sir Pangalos most recently served as Executive Vice President of Biopharmaceuticals R&D at AstraZeneca from 2019 up until his retirement in 2024. In this role, he was responsible for biopharmaceutical R&D from discovery through late-stage development, covering areas including cardiovascular, autoimmune and neurology.
He first joined AstraZeneca in 2010 as Executive Vice President of Early R&D and led the transformation of the company’s R&D productivity, as well as overseeing the creation of AstraZeneca’s new Global R&D Center in Cambridge, UK. Before his time at AstraZeneca, he held senior R&D roles at Pfizer, Wyeth and GSK. Prof Sir Pangalos obtained his Bachelor of Science in Biochemistry and Molecular Biology from Imperial College London and received his PhD in Neuropharmacology from University College London. He is an elected Fellow of the Royal Society, the Academy of Medical Sciences, the Royal Society of Biology and Clare Hall, University of Cambridge.
Prof Sir Pangalos also serves on the board of Absci Corporation.
Personal Details
Qualifications & Experience
Other directorships (state)
(only entities turnover at least $5m p/a)
Working history
Committee/s
| Company | Committee | Role | Appointment Date | Resignation Date |
|---|---|---|---|---|
| Biogen | Board | Member | 01/01/2025 | |
| Biogen | Remuneration | Member | 01/01/2025 |